CARBOXYMETHYLCELLULOSE SODIUM 0.5%

CARBOXYMETHYLCELLULOSE SODIUM 0.5% was reported 31 times

CARBOXYMETHYLCELLULOSE SODIUM 0.5% is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 POROKERATOSIS 1 0.0054
1 PERIORBITAL PAIN 1 0.0012
2 EYELID IRRITATION 1 0.0004
3 EYELID MARGIN CRUSTING 1 0.0003
4 SYNOVIAL CYST 1 0.0002
5 EYE PAIN 11 0.0002
6 FOREIGN BODY SENSATION IN EYES 1 0.0002
7 HYPOGAMMAGLOBULINAEMIA 1 0.0002
8 ULCER HAEMORRHAGE 1 0.0001
9 FACIAL PAIN 1 0.0001
10 PHOTOPHOBIA 2 0.0001
11 SINUS DISORDER 2 0.0001
12 FOOT DEFORMITY 1 0.0001
13 COVID-19 PNEUMONIA 1 0.0001
14 PRODUCT USE COMPLAINT 1 0.0001
15 PSYCHOMOTOR HYPERACTIVITY 1 0.0001
16 RESTLESS LEGS SYNDROME 1 0.0001
17 EYE IRRITATION 3 0.0001
18 ACUTE RESPIRATORY FAILURE 1 0.0001
19 PRODUCT ADMINISTRATION ERROR 1 0.0000
20 TOOTH DISORDER 1 0.0000
21 OCULAR HYPERAEMIA 2 0.0000
22 DRY EYE 2 0.0000
23 LACRIMATION INCREASED 1 0.0000
24 FUNGAL INFECTION 1 0.0000
25 THERAPY INTERRUPTED 2 0.0000
26 WHEEZING 1 0.0000
27 CATARACT 1 0.0000
28 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 3 0.0000
29 VISION BLURRED 2 0.0000
30 SLEEP DISORDER 1 0.0000
31 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
32 CARDIAC FAILURE CONGESTIVE 1 0.0000
33 THROMBOSIS 1 0.0000
34 NEUROPATHY PERIPHERAL 1 0.0000
35 MIGRAINE 1 0.0000
36 PRODUCT DOSE OMISSION ISSUE 3 0.0000
37 THROMBOCYTOPENIA 1 0.0000
38 LOSS OF CONSCIOUSNESS 1 0.0000
39 INSOMNIA 2 0.0000
40 DEHYDRATION 1 0.0000
41 ABDOMINAL DISCOMFORT 1 0.0000
42 COVID-19 1 0.0000
43 MUSCLE SPASMS 1 0.0000
44 NASOPHARYNGITIS 1 0.0000
45 ANAEMIA 1 0.0000
46 DIARRHOEA 3 0.0000
47 MALAISE 2 0.0000
48 DEPRESSION 1 0.0000
49 BACK PAIN 1 0.0000
50 COUGH 1 0.0000
51 PAIN 2 0.0000
52 PNEUMONIA 1 0.0000
53 FATIGUE 1 0.0000
54 NAUSEA 1 0.0000